CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS

High-grade malignant gliomas (WHO grade G III–IV) account for more than 50% of all primary brain tumors. Despite aggressive treatment, survival rates are still very low with a median reported survival of no more than 1.5 years.Radiation therapy is an integral part of the combined treatment, but ofte...

Full description

Saved in:
Bibliographic Details
Main Authors: Ye. L. Choinzonov, O. V. Gribova, Zh. A. Startseva, A. I. Ryabova, V. A. Novikov, L. I. Musabayeva, I. S. Polezhayeva
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2014-06-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/73
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839570062755758080
author Ye. L. Choinzonov
O. V. Gribova
Zh. A. Startseva
A. I. Ryabova
V. A. Novikov
L. I. Musabayeva
I. S. Polezhayeva
author_facet Ye. L. Choinzonov
O. V. Gribova
Zh. A. Startseva
A. I. Ryabova
V. A. Novikov
L. I. Musabayeva
I. S. Polezhayeva
author_sort Ye. L. Choinzonov
collection DOAJ
description High-grade malignant gliomas (WHO grade G III–IV) account for more than 50% of all primary brain tumors. Despite aggressive treatment, survival rates are still very low with a median reported survival of no more than 1.5 years.Radiation therapy is an integral part of the combined treatment, but often does not influence lethally on resistant tumor cells. Thereby, in recent decades there has been an active search for novel approaches to the treatment of malignant gliomas (chemotherapeutic drugs, biological modifiers, local hyperthermia). Experimental data showed that the effect of high temperatures has both a direct damaging effect on tumor cells and a sensitizing effect. Significant advantages are achieved when the complex treatment of different malignant tumorsincludes local hyperthermia. However data on the treatment of patients with primary and recurrent gliomas G III–IV using local hyperthermia are scarce.The literature review is given in the article provides an overview of the existing treatment methods for brain tumors.
format Article
id doaj-art-0e4611f23cbe4af1a3ea6c7d026098a4
institution Matheson Library
issn 1682-0363
1819-3684
language English
publishDate 2014-06-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj-art-0e4611f23cbe4af1a3ea6c7d026098a42025-08-04T16:45:37ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842014-06-0113311912510.20538/1682-0363-2014-3-119-12571CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMASYe. L. Choinzonov0O. V. Gribova1Zh. A. Startseva2A. I. Ryabova3V. A. Novikov4L. I. Musabayeva5I. S. Polezhayeva6Cancer Research Institute, Siberian Branch of the Russian Academy of Medical Sciences, TomskCancer Research Institute, Siberian Branch of the Russian Academy of Medical Sciences, TomskCancer Research Institute, Siberian Branch of the Russian Academy of Medical Sciences, TomskCancer Research Institute, Siberian Branch of the Russian Academy of Medical Sciences, TomskCancer Research Institute, Siberian Branch of the Russian Academy of Medical Sciences, TomskCancer Research Institute, Siberian Branch of the Russian Academy of Medical Sciences, TomskCancer Research Institute, Siberian Branch of the Russian Academy of Medical Sciences, TomskHigh-grade malignant gliomas (WHO grade G III–IV) account for more than 50% of all primary brain tumors. Despite aggressive treatment, survival rates are still very low with a median reported survival of no more than 1.5 years.Radiation therapy is an integral part of the combined treatment, but often does not influence lethally on resistant tumor cells. Thereby, in recent decades there has been an active search for novel approaches to the treatment of malignant gliomas (chemotherapeutic drugs, biological modifiers, local hyperthermia). Experimental data showed that the effect of high temperatures has both a direct damaging effect on tumor cells and a sensitizing effect. Significant advantages are achieved when the complex treatment of different malignant tumorsincludes local hyperthermia. However data on the treatment of patients with primary and recurrent gliomas G III–IV using local hyperthermia are scarce.The literature review is given in the article provides an overview of the existing treatment methods for brain tumors.https://bulletin.ssmu.ru/jour/article/view/73malignant gliomascombined modality treatmentchemotherapylocal hyperthermia
spellingShingle Ye. L. Choinzonov
O. V. Gribova
Zh. A. Startseva
A. I. Ryabova
V. A. Novikov
L. I. Musabayeva
I. S. Polezhayeva
CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS
Бюллетень сибирской медицины
malignant gliomas
combined modality treatment
chemotherapy
local hyperthermia
title CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS
title_full CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS
title_fullStr CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS
title_full_unstemmed CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS
title_short CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS
title_sort current approaches to chemoradiotherapy for malignant gliomas
topic malignant gliomas
combined modality treatment
chemotherapy
local hyperthermia
url https://bulletin.ssmu.ru/jour/article/view/73
work_keys_str_mv AT yelchoinzonov currentapproachestochemoradiotherapyformalignantgliomas
AT ovgribova currentapproachestochemoradiotherapyformalignantgliomas
AT zhastartseva currentapproachestochemoradiotherapyformalignantgliomas
AT airyabova currentapproachestochemoradiotherapyformalignantgliomas
AT vanovikov currentapproachestochemoradiotherapyformalignantgliomas
AT limusabayeva currentapproachestochemoradiotherapyformalignantgliomas
AT ispolezhayeva currentapproachestochemoradiotherapyformalignantgliomas